期刊文献+

低分子肝素治疗老年不稳定型心绞痛疗效观察

下载PDF
导出
摘要 目的 :探讨低分子肝素治疗老年不稳定型心绞痛的临床疗效。方法 :老年不稳定型心绞痛患者 6 0例随机分成两组。治疗组 30例采用复方丹参注射液 14 ml,静脉滴注 ,1次 / d;硝酸异山梨醇酯 10 mg/次 ,3次 / d,口服 ;同时予低分子肝素 (速必凝 ) 0 .4 ml/次 ,皮下注射 ,2次 / d,连用 10 d。对照组 30例除不用低分子肝素外 ,余治疗同治疗组。两组均观察心绞痛的发作次数、常规心电图∑ST及副作用发生率。结果 :治疗组临床总疗效明显高于对照组 (P <0 .0 5 ) ,治疗期间无 AMI及猝死的发生 ,对照组发生 2例 AMI和 4例严重心律失常 ,两组比较差异有统计学意义 (P <0 .0 5 )。治疗组心绞痛的发作次数与治疗前比较明显减少 (P <0 .0 1)、常规心电图∑ST与治疗前比较明显改善 (P <0 .0 1) ,两组对血小板、凝血酶原时间、国际化比值、活化的部分凝血活酶时间均无明显影响 (P >0 .0 5 )。结论 :低分子肝素治疗老年不稳定型心绞痛 ,疗效确切、安全 。
出处 《广西医科大学学报》 CAS 2004年第6期885-886,共2页 Journal of Guangxi Medical University
  • 相关文献

参考文献5

二级参考文献14

  • 1[1]Gurfinkel EP,Manos EJ,Mejail RI,et al.Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia.J Am Coll Cardiol.1995,26:313~318.
  • 2[2]Fragmin During Instability in Coronary Artery Disease(FRISC) study group.Low molecular weight heparin during instability in CAD.Lancet.1996,347:561~568.
  • 3[3]FRAX.I.S study group.Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction:FRAX.I.S.(FRAxiparine in Ischaemic Syndrome).Eur Heart J.1999,20(21):1553~1562.
  • 4[4]Klein W,Buchwald A,Hillis SE,et al.Comparison of low molecular weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease.Fragmin in unstable coronary artery disease study (FRIC).Circulation.1997,96:61~68.
  • 5[5]Cohen M,Demers C,Gurfinkel FP,et al.A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease.N Ehgl J Med.1997,337:447~452.
  • 6[6]Antman EM,Mcgabe CH,Gurfinkel EP,et al.For the TIMI 11B Investigators.Enoxaparin prevents death and cardiac ischemic events in unstable angina/non Q-wave myocardial infarction:results of the thrombolysis in myocardial infarction (TIMI) 11B trial.Circulation.1999,100:1593~1601.
  • 7[7]Fragmin and fast revascularization during instability in coronary artery disease (FRISC Ⅱ) investigators.Long-term low molecular mass heparin in unstable coronary artery disease:FRISC Ⅱ prospective randomized multicentre study.Fragmin and fast revascularisation during instability in coronary artery disease.Investigators.Lancet.1999,354:701~707.
  • 8[8]Weita JI.Low-molecular-weight heparins.N Engl J Med.1997,338:688~698.
  • 9[9]Samama MM,Bara L,Gouin-Thibault.New data on the pharmacology of heparin and low molecular weight heparins.Drugs.1996,52(7):8~15.
  • 10[10]Monrad ES.Role of low molecular weight heparins in the management of patients with unstable angina pectoris and non Q wave acute myocardial infarction.Am J Cardiol.2000,85:2C~9C.

共引文献2698

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部